The Kingdom of Saudi Arabia is emerging as a pivotal region in the global harm reduction conversation, with momentum growing around novel nicotine products like oral pouches. At the recent Tobacco and Nicotine-Free Summit (TNFS), Dr. Christopher Russell, a behavioral scientist and harm reduction expert, outlined critical next steps for advancing nicotine policy in the Kingdom—steps that are equally relevant for other markets in the Middle East.
A Region at a Crossroads
With a high prevalence of smoking and limited access to reduced-risk alternatives, Saudi Arabia represents both a challenge and an opportunity for public health advocates. Dr. Russell emphasized that nicotine policy in the Kingdom must balance cultural, health, and regulatory factors while aligning with international scientific consensus on risk-proportionate approaches.
The Role of Oral Nicotine Pouches
Among the alternatives discussed, oral nicotine pouches stand out for their discreet format, reduced harm profile, and appeal to current smokers seeking to quit combustible tobacco. Data from international markets consistently show that pouches are effective substitutes, particularly in regions where vaping faces cultural or regulatory barriers.
Dr. Russell argued that regulating nicotine pouches in Saudi Arabia could help the Kingdom meet its national smoking reduction targets under Vision 2030, offering a viable off-ramp for millions of adult smokers.
What Science Says
The TNFS presentation highlighted growing evidence on:
- The low toxicant profile of oral nicotine pouches compared to combustible tobacco
- The substitution effect—where pouch users reduce or eliminate cigarette use
- Consumer patterns showing limited appeal of pouches among non-nicotine users, reducing the risk of youth uptake
Dr. Russell called on Saudi regulators to prioritize scientific evidence in shaping policy.
A Call for Balanced Regulation
Rather than prohibition, the presentation advocated for:
- Age restrictions (18+)
- Clear labeling and health warnings
- Nicotine content limits
- Sales only through licensed outlets
- A dedicated scientific advisory body to monitor impact
These measures would ensure consumer safety while preserving access to safer alternatives for adult smokers.
GINN’s Perspective
At the Global Institute for Novel Nicotine (GINN), we echo Dr. Russell’s message. Effective regulation of oral nicotine products is not about endorsing nicotine use—it’s about providing adult smokers with options that reduce harm, particularly in countries where smoking rates remain high.
As Saudi Arabia and other Middle Eastern nations deliberate their next steps, GINN stands ready to support evidence-based policy development that protects public health, respects cultural values, and enables responsible innovation.
For more updates on nicotine policy across the MENA region and beyond, visit www.ginn.global
Sources:
